| 2026-05-11 |
详情>>
股本变动：
变动后总股本7260.19万股
|
| 2026-05-11 |
详情>>
业绩披露：
2026年一季报每股收益-0.18美元,归母净利润-1776.5万美元,同比去年增长2.00%
|
| 2026-05-11 |
财报披露：
美东时间 2026-05-11 盘后发布财报
|
| 2026-03-20 |
详情>>
业绩披露：
2025年年报每股收益-0.67美元,归母净利润-6759.3万美元,同比去年增长-83.87%
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.41美元,归母净利润-4127.5万美元,同比去年增长3.30%
|
| 2025-08-04 |
详情>>
业绩披露：
2025年中报每股收益-0.42美元,归母净利润-4186.3万美元,同比去年增长-113.29%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.18美元,归母净利润-1812.8万美元,同比去年增长-421.25%
|
| 2025-03-14 |
详情>>
业绩披露：
2024年年报每股收益-0.41美元,归母净利润-3676.1万美元,同比去年增长63.62%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.49美元,归母净利润-4268.3万美元,同比去年增长27.98%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.24美元,归母净利润-1962.7万美元,同比去年增长53.02%
|
| 2024-05-28 |
详情>>
业绩披露：
2024年一季报每股收益0.08美元,归母净利润564.30万美元,同比去年增长118.76%
|
| 2024-05-24 |
股东大会：
将于2024-06-28召开股东大会
会议内容 ▼▲
- 1.Approval of the annual financial statements for the financial year ended December 31, 2023.
2.Approval of the consolidated financial statements for the financial year ended December 31, 2023.
3.Allocation of the results for the financial year ended December 31, 2023.
4.Allocation of losses carried forward to the “share premium” account.
5.Review of the agreements considered in articles L. 225-38 et seq. of the French Commercial Code (financing agreement with Bpifrance).
6.Review of the agreements considered in articles L. 225-38 et seq. of the French Commercial Code (subsidy and repayable advance agreement with Bpifrance).
7.Renewal of the appointment of Mr. André Choulika as a member of the board of directors.
8.Renewal of the appointment of Mr. David Sourdive as a member of the board of directors.
9.Renewal of the appointment of J.M.H. Conseil as statutory auditor.
10.Appointment of KPMG as statutory auditor.
11.Authorization to the Board of Directors to buy back shares of the Company.
12.Authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization for to buy back its own shares.
13.Up-date of Article 24 of the articles of association “Loss of one half of share capital” in order to comply with legal provisions.
14.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities, with cancellation of shareholders’ preferential subscription rights in favor of the European Investment Bank or of other entities that may succeed EIB, according to any finance agreement entered or be entered.
15.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with experience in the health or biotech sector).
16.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (credit institutions, investment services providers or members of an investment pool guaranteeing the completion of the considered issue).
17.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any other securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (industrial companies, institutions or entities active in the health or biotechnology sector).
18.Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics the framework of an equity or bond financing agreement.
19.Delegation of authority to be granted to the Board of Directors to decide on the issuance of ordinary shares to be issued immediately or in the future by the Company, with cancellation of the shareholders’ preferential subscription rights, to the benefit of a category of persons meeting specified characteristics within the framework of an equity financing program on the American market known as “At-the-market” or “ATM”.
20.Delegation of authority to be granted to the Board of Directors to immediately or in the future increase the share capital by issuing ordinary shares or any other securities giving access to the share capital, with the shareholders’ preferential subscription rights maintained.
21.Delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of the shareholders’ pre-emptive subscription rights by way of a public offering (other than the offers referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code).
22.Delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of’ pre-emptive subscription rights by way of an offering referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code.
23.Delegation of authority to be granted to the Board of Directors to increase the amount of each of the issues with or without pre-emptive subscription rights which will be decided pursuant to the above delegations.
24.Determination of the total amount of the capital increases that may be carried out under the aforementioned delegations (excluding the share capital increase with upholding of the shareholders’ preferential subscription rights and the share capital increase in favor of the European Investment Bank or of other entities that may succeed EIB, according to any finance agreement).
25.Delegation of authority to be granted to the board of directors to increase the capital by incorporation of premiums, reserves, profits or other.
26.Authorization to be granted to the Board of Directors to grant options to subscribe for or purchase ordinary shares in the Company, entailing a waiver by the shareholders of their preferential subscription rights.
27.Authorization to be granted to the Board of Directors to proceed with free allocations of ordinary shares of the Company, to the benefit of employees and/or corporate officers of the Company and its subsidiaries, entailing the waiver by the shareholders of their preferential subscription rights.
28.Determination of the total amount of the capital increases that may be carried out by virtue of the aforementioned authorization to grant options to subscribe for or purchase shares and the aforementioned authorization to grant free shares.
29.Delegation of authority to be granted to the Board of Directors for the purpose of carrying out a capital increase whose subscription will be reserved for members of a company savings plan established pursuant to Articles L. 3332-1 et seq. of the Labor Code.
|
| 2024-04-29 |
详情>>
业绩披露：
2023年年报每股收益-1.77美元,归母净利润-1.01亿美元,同比去年增长4.79%
|
| 2023-11-17 |
股东大会：
将于2023-12-22召开股东大会
会议内容 ▼▲
- 1.Creation of a class of preferred shares referred to as “Class A preferred shares” convertible into ordinary shares (the “A Shares”) - determination of the specific rights attached to the A Shares - corresponding amendment to the bylaws
2.Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 500,000, through the issuance of a maximum of 10,000,000 A Shares, with cancellation of the shareholders’ preferential subscription rights in favor of a named person
3.Creation of a class of preferred shares referred to as “Class B preferred shares” convertible into ordinary shares (the “B Shares”) - determination of the specific rights attached to the B Shares - corresponding amendment to the bylaws
4.Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 900,000, through the issuance of a maximum of 18,000,000 B Shares, with cancellation of the shareholders’ preferential subscription rights in favor of a named person
5.Cancellation of the shareholders’ preferential subscription rights in favor of AstraZeneca Holdings B.V.
6.Delegation of authority to the board of directors to carry out a share capital increase reserved for members of a company savings plan set up in accordance with Articles L. 3332-1 et seq. of the French Labor Code.
7.Appointment of a director (identity to be completed on convening of the meeting) subject to condition precedent
8.Appointment of a director (identity to be completed on convening of the meeting) subject to condition precedent.
|
| 2023-05-22 |
股东大会：
将于2023-06-27召开股东大会
会议内容 ▼▲
- 1.Management report of the Board of Directors including the report on corporate governance and presentation by the Board of the annual financial statements for the financial year ended December 31, 2022.
2.Reports of the auditors on the annual financial statements and the agreements referred to in Article L. 225-38 of the Commercial Code.
3.Approval of the annual financial statements for the financial year ended December 31, 2022.
4.Auditors’ report on the consolidated financial statements for the financial year ended December 31, 2022.
5.Management report of the Group and presentation by the auditor of the annual financial statements for the financial year ended December 31, 2022.
6.Approval of the consolidated financial statements for the financial year ended December 31, 2022.
7.Appropriation of results for the financial year ended December 31, 2022.
8.Allocation of losses carried forward to the “share premium” account.
9.Review of the agreements considered in articles L. 225-38 et seq. of the Commercial Code.
10.Renewal of the appointment of Mr. Jean-Pierre Garnier.
11.Renewal of the appointment of Mr. Laurent Arthaud.
12.Renewal of the appointment of Mr. Pierre Bastid.
13.Renewal of the appointment of Mr. Rainer Boehm.
14.Appointment of a new director.
15.Authorization to the Board of Directors to buy back shares of the Company.
|
| 2022-05-23 |
股东大会：
将于2022-06-28召开股东大会
会议内容 ▼▲
- 1.Management report of the Board of Directors including the report on corporate governance and presentation by the Board of the annual financial statements for the financial year ended 31 December 2021,
2.Reports of the auditors on the annual financial statements and the agreements referred to in Article L. 225-38 of the Commercial Code,
3.Approval of the annual financial statements for the financial year ended 31 December 2021,
4.Auditors’ report on the consolidated financial statements for the financial year ended 31 December 2021,
5.Management report of the Group and presentation by the auditor of the annual financial statements for the financial year ended 31 December 2021,
6.Approval of the consolidated financial statements for the financial year ended 31 December 2021,
7.Appropriation of results for the financial year ended 31 December 2021,
8.Allocation of losses carried forward to the “share premium” account,
9.Setting the amount of the total remuneration allocated to the non-executive members of the Board of Directors,
10.Ratification of the appointment of an Observer decided by the Board of Directors,
11.Appointment of a new director (Mr Donald Bergstrom),
12.Appointment of a new director (Mr Axel-Sven Malkomes),
13.Authorization to the Board of Directors to buy back shares of the Company,
14.Authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization for to buy back its own shares,
15.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with experience in the health or biotech sector),
delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (credit institution, investment services provider or member of an investment pool guaranteeing the completion of the considered issue),
16.Delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any other securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (industrial companies, institutions or entities active in the health or biotechnology sector),
17.Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics the framework of an equity or bond financing agreement,
18.Delegation of authority to be granted to the Board of Directors to decide on the issuance of ordinary shares to be issued immediately or in the future by the Company, with cancellation of the shareholders’ preferential subscription rights, to the benefit of a category of persons meeting specified characteristics within the framework of an equity financing program on the American Market known as “At-the-market” or “ATM”,
19.Delegation of authority to be granted to the Board of Directors to immediately or in the future increase the share capital by issuing ordinary shares or any other securities giving access to the share capital, with the shareholders’ preferential subscription rights maintained,
20.Delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of’ pre-emptive subscription rights by way of a public offering (other than the offers referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code).
21.Delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of’ pre-emptive subscription rights by way of an offering referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code.
22.Delegation of authority to be granted to the Board of Directors to increase the amount of each of the issues with or without pre-emptive subscription rights which will be decided pursuant to the above delegations.
23.Determination of the total amount of the capital increases that may be carried out under the aforementioned delegations,
24.Delegation of authority to be granted to the board of directors to increase the capital by incorporation of premiums, reserves, profits or other,
25.Duthorization to be granted to the Board of Directors to grant options to subscribe for or purchase ordinary shares in the Company, entailing a waiver by the shareholders of their preferential subscription rights,
26.Authorization to be granted to the Board of Directors to proceed with free allocations of ordinary shares of the Company, to the benefit of employees and/or corporate officers of the Company and its subsidiaries, entailing the waiver by the shareholders of their preferential subscription rights,
27.Aelegation of authority to be granted to the Board of Directors to allocate share warrants giving the right to subscribe to ordinary shares of the Company—suppression of the preferential subscription right in favor of a category of persons meeting specific characteristics: (i) members and overseers of the Board of Directors of the Company in office at the date of allocation of the warrants who are not employees or officers of the Company or any of its subsidiaries, or (ii) persons bound by a service or consultancy contract with the Company or any of its subsidiaries, or (iii) members of any committee that the Board of Directors has set up or may set up who are not employees or officers of the Company or any of its subsidiaries,
28.Determination of the total amount of the capital increases that may be carried out by virtue of the aforementioned authorizations,
29.Delegation of authority to be granted to the Board of Directors for the purpose of carrying out a capital increase whose subscription will be reserved for members of a company savings plan established pursuant to Articles L. 3332-1 et seq. of the Labor Code.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-06-01召开股东大会
会议内容 ▼▲
- Agenda of the ordinary shareholders’ meeting
1.management report of the board of directors, including the report on corporate governance, and presentation by the board of the annual financial statements for the financial year ended December 31, 2020,
2.statutory auditors’ reports on the annual financial statements and the agreements referred to in article L.225-38 of the French commercial code,
3.approval of the annual financial statements for the financial year ended December 31, 2020,
4.statutory auditors’ reports on the consolidated financial statements for the financial year ended December 31, 2020,
5.group management report and presentation of the consolidated financial statements for the financial year ended December 31, 2020 by the board,
6.approval of the consolidated financial statements for the financial year ended December 31, 2020,
7.earnings allocation for the financial year ended December 31, 2020,
8.review of the agreements referred to in articles L.225-38 et seq.of the French commercial code,
9.setting of the amount of the total compensation to be granted to the non-executive directors,
10.renewal of the appointment of Mr.André Choulika as a member of the board of directors,
11.renewal of the appointment of Mr.David Sourdive as a member of the board of directors,
12.renewal of the appointment of Mr.Alain-Paul Godard as a member of the board of directors,
13.authorization to be given to the board of directors to buy back Company shares,
Agenda of the extraordinary shareholders’ meeting
1.authorization to be granted to the board of directors to reduce the Company’s share capital by cancelling shares in the context of the authorization granted to the board of directors to buy back Company shares,
2.delegation of authority to be granted to the board of directors to increase the share capital by issuing ordinary shares or any securities, with cancellation of the shareholders’ preferential subscription rights, in favor of a category of persons meeting specified characteristics (investors having experience in the health or biotechnology sector),
3.delegation of authority to be granted to the board of directors to increase the share capital by issuing ordinary shares or any securities, with cancellation of the shareholders’ preferential subscription rights, in favor of a category of persons meeting specified characteristics (credit institution, investment services provider or syndicate member guaranteeing the completion of the considered issuance),
4.delegation of authority to be granted to the board of directors to increase the share capital by issuing ordinary shares or any securities, with cancellation of the shareholders’ preferential subscription rights, in favor of a category of persons meeting specified characteristics (industrial companies, institutions or entities active in the health or biotechnology sector),
5.delegation of authority to be granted to the board of directors to increase the share capital by issuing ordinary shares or any securities, with cancellation of the shareholders’ preferential subscription rights, in favor of a category of persons meeting specified characteristics, in the context of equity or bond financing,
6.delegation of authority to be granted to the board of directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities giving access to the share capital, while preserving the shareholders’ preferential subscription rights,
7.delegation of authority to be granted to the board of directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities giving access to the share capital, with cancellation of the shareholders’ preferential subscription rights, through a public offer (excluding offers referred to in paragraph 1° of article L. 411-2 of the French monetary and financial code),
8.delegation of authority to be granted to the board of directors to increase the share capital by issuing ordinary shares or any securities, with cancellation of the shareholders’ preferential subscription rights, through an offer referred to in paragraph 1° of article L. 411-2 of the French monetary and financial code,
9.delegation to be granted to the board of directors in order to increase the number of securities to be issued as a result of a share capital increase with or without preferential subscription rights performed pursuant to the aforementioned delegations,
10.overall limitations to the amount of the share capital increases that could be completed pursuant to the aforementioned delegations,
11.delegation of authority to be granted to the board of directors to increase the share capital by way of incorporation of premiums, reserves, profits or others,
12.authorization to be granted to the board of directors to grant options to subscribe or purchase ordinary shares of Company shares, entailing a waiver by the shareholders of their preferential subscription rights,
13.authorization to be granted to the board of directors to grant free shares of the Company to employees and/or corporate officers of the Company and of its subsidiaries, entailing a waiver by the shareholders of their preferential subscription rights,
14.overall limitations to the amount of the share capital increases that could be completed pursuant to the above authorizations,
15.amendment of Article 18 of the by-laws relating to shareholders meetings (clarification of voting procedures)
16.delegation to be granted to the board of directors to increase the Company’s share capital for the benefit of employees who are members of a company savings plan(s) (plan d’épargne d’entreprise) implemented pursuant to articles L. 3332-1 and following of the French labor code.
|
| 2020-10-16 |
股东大会：
将于2020-11-04召开股东大会
会议内容 ▼▲
- 1.the appointment of Mr. Jean-Pierre Garnier as a new board member
2.an amendment to the age limit applicable to directors, the chief executive officer and deputy chief executive officers.
|
| 2020-05-08 |
股东大会：
将于2020-06-29召开股东大会
会议内容 ▼▲
- Agenda of the ordinary shareholders’ meeting
1.Board of directors’ management report, including the report on corporate governance, and presentation by the board of the annual financial statements for the financial year ended December 31, 2019,
2.Statutory auditors’ reports on the financial statements and the agreements referred to in article L. 225-38 of the French commercial code,
3.Approval of the financial statements for the financial year ended December 31,2019,
4.Statutory auditors’ reports on the consolidated financial statements for the financial year ended December 31, 2019,
5.Company’s management report and presentation by the supervisory board of the consolidated financial statements for the financial year ended December 31, 2019,
6.Approval of the consolidated financial statements for the financial year ended December 31, 2019,
7.Allocation of income for the financial year ended December 31, 2019,
8.Review of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code,
9.Setting the amount of the total compensation for non-executive directors,
10.Renewal of the mandate of a member of the Board of Directors of Annick Schwebig,
11.Renewal of the mandate of a member of the Board of Directors of Laurent Arthaud,
12.Renewal of the mandate of a member of the Board of Directors of Pierre Bastid,
13.Renewal of the mandate of a member of the Board of Directors of Rainer Boehm,
14.Renewal of the mandate of a member of the Board of Directors of Hervé Hoppenot,
15.Authorization to be given to the board of directors to buy back Company shares,
Agenda of the extraordinary shareholders’ meeting
16.Authorization to be given to the board of directors for the purpose of reducing the share capital through the cancellation of shares in the context of the authorization to buy back its own shares,
17.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of categories of persons meeting specified characteristics,
18.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a first category of persons meeting specified characteristics
19.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a second category of persons meeting specified characteristics
20.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares or of any securities with a waiver of the preferential subscription rights, in favor of a category of persons taking part to a line of equity financing or bond financing,
21.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in the future by issuing ordinary shares or any securities, while maintaining the preferential subscription rights of shareholders,
22.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or any securities, with waiver of the preferential subscription rights of the shareholders, through a public offering,
23.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or of any securities, with waiver of the preferential subscription rights of the shareholders, through an offer referred to in article L. 411-2 of the French monetary and financial code.
24.Delegation granted to the board of directors to increase the number of securities to be issued in case of share capital increase with or without preferential subscription rights,
25.Overall limitations to the amount of issuances made under the above resolutions,
26.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by incorporation of premiums, reserves, profits or others,
27.Authorization to be given to the board of directors to grant options to subscribe or purchase Company’s shares,
28.Authorization be given to the board of directors for the allocation of free shares existing and/or to be issued in the future,
29.Delegation of authority to be granted to the board of directors to issue warrants giving the right to subscribe ordinary shares of the Company – Cancellation of the preferential right of subscription to the benefit of a category of persons meeting specific characteristics : (i) members and observers (censeurs) of the Company’s board of directors in office on the date the warrants are granted who are not employees or senior executives of the Company or of one of its subsidiaries or (ii) persons who have entered into a service or consultant contract with the Company or with one of its subsidiaries or (iii) members of any committee which the board or of directors has set up or could set up who are not employees or senior executives of the Company or of one of its subsidiaries.
30.Overall limitations to the amount of issues made under the above resolutions.
31.Amendment of article 12 of the articles of association “meeting of the board of directors” in order to provide for the possibility for the board of directors to take certain decisions by means of written consultation,
32.Amendment of Article 18 of the Articles of Association “General Meetings - quorum - voting - number of votes” in order to update the legal provisions concerning the procedures for determining the majority required for the adoption of resolutions by general meetings of shareholders,
33.Delegation to be granted to the board of directors for the purpose of an increase in the share capital whose subscription would be reserved to members of a company savings plan established pursuant to articles L. 3332-1 and following of the French labor code
|
| 2020-03-17 |
复牌提示：
2020-03-16 09:50:48 停牌，复牌日期 2020-03-16 10:00:48
|
| 2019-05-03 |
股东大会：
将于2019-06-25召开股东大会
会议内容 ▼▲
- Agenda of the ordinary shareholders’ meeting
1.Reading of the board of directors’ management report and the presentation by the board of the annual financial statements for the financial year ended December 31, 2018,
2.Reading of the statutory auditors’ reports on the performance of their assignment during the aforementioned financial year and the agreements referred to in article L. 225-38 of the French commercial code,
3.Approval of the financial statements for the financial year ended December 31, 2018,
4.Reading of the statutory auditors’ reports on the consolidated financial statements for the financial year ended December 31, 2018,
5.Reading of the Company’s management report and of the consolidated financial statements for the financial year ended December 31, 2018,
6.Approval of the consolidated financial statements for the financial year ended December 31, 2018,
7.Allocation of income for the financial year ended December 31, 2018,
8.Review of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code,
9.Approval for the regulation pertaining to the stock options or stock purchase plan (“2018 Stock Option Plan”) adopted by the board of directors on August 1, 2018.
10.Authorization to be given to the board of directors to buy back Company shares.
Agenda of the extraordinary shareholders’ meeting
11.Authorization to be given to the board of directors for the purpose of reducing the share capital through the cancellation of shares in the context of the authorization to buy back its own shares,
12.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in the future by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of categories of persons meeting specific characteristics;
13.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in the future by issuing ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a category of persons meeting specific characteristics;
14.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares or of any securities with a waiver of the preferential subscription rights of the shareholders, in favor of a category of persons ensuring the underwriting of the Company’s equity securities that may arise as part of an equity line financing or bond financing,
15.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares or any securities while maintaining the preferential subscription rights of the shareholders,
16.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or any securities, with a waiver of the preferential subscription rights of the shareholders through a public offering,
17.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or of any securities, with a waiver of the preferential subscription rights of the shareholders, through an offer to qualified investors or a restricted circle of investors within the meaning of paragraph II of article L. 411-2 of the French monetary and financial code,
18.Delegation granted to the board of directors to increase the number of securities to be issued in case of any share capital increase with or without preferential subscription rights,
19.Setting the overall limitations to the amount of issuances made under the above mentioned delegation,
20.Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by incorporation of premiums, reserves, profits or others,
21.Authorization to be given to the board of directors to grant options to subscribe for or purchase Company’s shares,
22.Authorization to be given to the board of directors for the allocation of free shares existing and/or to be issued in the future,
23.Delegation of authority to be granted to the board of directors to issue warrants to the benefit of a category of persons meeting specific characteristics: (i) members and observers (censeurs) of the Company’s board of directors in office on the date the warrants are granted who are not employees or senior executives of the Company or of one of its subsidiaries or (ii) persons who have entered into a service or consultant contract with the Company or with one of its subsidiaries or (iii) members of any committee which the board of directors has established or could establish who are not employees or senior executives of the Company or of one of its subsidiaries,
24.Delegation of authority to be granted to the board of directors for the purpose of issuing warrants to subscribe to and/or acquire redeemable shares (BSAAR) or share subscription warrants, with a waiver of the preferential subscription rights of the shareholders in favor of the following category of beneficiaries: employees and corporate officers of the Company and its subsidiaries,
25.Authorization for the board of directors to freely allocate preferred shares of the Company to the employees and/or the executive officers of the Company and its subsidiaries entailing the waiver by the shareholders of their preferential subscription rights,
26.Setting the overall limitations to the amount of issues made under the above-mentioned authorizations and delegations,
27.Delegation to be granted to the board of directors for the purpose of an increase in the share capital whose subscription would be reserved to members of a company savings plan established pursuant to articles L. 3332-1 and following of the French labor code.
|
| 2018-05-09 |
股东大会：
将于2018-06-26召开股东大会
会议内容 ▼▲
- 1.Reading of the board of directors’ management report and the presentation by the board of the annual financial statements for the financial year ended December 31, 2017,
2.Reading of the statutory auditors’ reports on the performance of their assignment during the aforementioned financial year and the agreements referred to in article L. 225-38 of the French commercial code,
3.Approval of the financial statements for the financial year ended December 31, 2017,
4.Reading of the statutory auditors’ reports on the consolidated financial statements for the financial year ended December 31, 2017,
5.Reading of the Company’s management report and of the consolidated financial statements for the financial year ended December 31, 2017,
6.Approval of the consolidated financial statements for the financial year ended December 31, 2017,
7.Allocation of income for the financial year ended December 31, 2017,
8.Review of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code,
9.Setting the amount of the attendance fees for non-executive directors,
10.Renewal of the term of office of director of Mr. André Choulika,
11.Renewal of the term of office of director of Mr. David Sourdive,
12.Renewal of the term of office of director of Mr. Alain Godard, independent director according to the rules of the U.S. Securities and Exchange Act of 1934 (the “Exchange Act”) and Nasdaq Stock Market,
13.Renewal of the term of office of J.M.H. Conseil, as the Company’s Statutory Auditors,
14.Renewal of the term of office of Ernst & Young et Autres, as the Company’s Statutory Auditors,
15.Approval for the regulation pertaining to the stock options or stock purchase plan adopted by the Board of Directors on October 11, 2017.
16.Authorization to be given to the board of directors to buy back Company shares.
|
| 2017-08-02 |
股东大会：
将于2017-06-26召开股东大会
|
| 2016-03-31 |
股东大会：
将于2016-05-17召开股东大会
会议内容 ▼▲
- Ordinary General Meeting
1. Approval of the annual financial statements for the fiscal year ended December 31, 2015
2. Approval of the consolidated financial statements for the fiscal year ended December 31, 2015
3. Allocation of income for the fiscal year ended December 31, 2015
4. Approval of the agreements referred to in articles L. 225-38 and following of the French commercial code
5. Reappointment of Mr. Mathieu Simon to the board of directors
6. Authorization to be given to the board of directors to buy back Company shares
Extraordinary General Meeting
7. Authorization to be given to the board of directors for the purpose of reducing the share capital through the cancellation of shares in the context of the authorization to buy back its own shares
8. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and/or any securities giving access immediately or in the future to the share capital and/or giving entitlement to the allotment of debt securities, with a waiver of the preferential subscription rights, in favor of a category of persons meeting specified characteristics
9. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares or of any securities with a waiver of the preferential subscription rights, in favor of a category of persons ensuring the underwriting of the Company’s equity securities that may arise as part of a line of equity financing
10. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in future by issuing ordinary shares or any securities giving access immediately or in the future to the share capital or giving entitlement to the allotment of debt securities, while maintaining the preferential subscription rights
11. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in the future through the issuance of ordinary shares or of any securities giving access immediately or in the future to the share capital or giving entitlement to the allotment of debt securities, with a waiver of the preferential subscription rights and public offerin
12. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and/or of any securities giving access immediately or in the future to the share capital or giving entitlement to the allotment of debt securities, with a waiver of the preferential subscription rights of the shareholders, through an offer to qualified investors or a limited circle of investors within the meaning of paragraph II of article L. 411-2 of the French monetary and financial code
13. Delegation granted to the board of directors to increase the number of securities to be issued in case of share capital increase with or without preferential subscription rights
14. Overall limitations to the amount of issuances made under the Eighth resolution, the Ninth resolution, the Tenth resolution, the Eleventh resolution, the Twelfth resolution and the Thirteenth resolution above
15. Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by incorporation of premiums, reserves, profits or others
16. Authorization to be given to the board of directors to grant options to subscribe or purchase Company’s shares
17. Authorization be given to the board of directors for the allocation of free shares existing and/or to be issued in the future
18. Delegation of authority to be granted to the board of directors to issue and grant share warrants to (i) members and non-voting members (censeurs) of the Company’s board of directors in office on the date the warrants are granted who are not employees or senior executives of the Company or one of its subsidiaries or (ii) persons who have entered into a services or consultants contract with the Company or with one of its subsidiaries or (iii) members of any committee which the board or of directors has set up or could set up who are not employees or directors of the Company or of one of its subsidiaries
19. Delegation of authority to be granted to the board of directors for the purpose of issuing warrants to subscribe to and/or acquire redeemable shares (BSAAR) or share subscription warrants - with a waiver of the preferential subscription rights in favor of the following category of beneficiaries: employees and corporate officers of the Company and its subsidiaries
20. Authorization for the board of directors to freely allocate preferred shares of the Company to the employees and and/or the executive officers of the Company and its subsidiaries entailing the waiver by the shareholders of their preferential subscription rights
21. Overall limitations to the amount of issues made under the Sixteenth resolution, the Seventeenth resolution, the Eighteenth resolution, the Nineteenth resolution and the Twentieth resolution above
22. Delegation to be granted to the board of directors for the purpose of an increase in the share capital whose subscription would be reserved to members of a company savings plan established pursuant to articles L. 3332-18 and following of the French labor code
|
| 2015-04-27 |
股东大会：
将于2015-05-18召开股东大会
会议内容 ▼▲
- Agenda for the Ordinary General Meeting
1.Reading of the Board of Directors’ management report and presentation by the Board of Directors of the annual financial statements for the fiscal year ended December 31, 2014,
2.Reading of the Statutory Auditors’ Reports on the performance of their duty during the aforementioned fiscal year and the agreements referred to in article L. 225-38 of the French Commercial Code (Code de Commerce),
3.Approval of the annual financial statements for the fiscal year ended December 31, 2014,
4.Reading of the Statutory Auditors’ Reports on the consolidated financial statements for the fiscal year ended December 31, 2014,
5.Reading of the management report regarding the group and presentation by the Board of Directors of the consolidated financial statements for the fiscal year ended December 31, 2014,
6.Approval of the consolidated financial statements for the fiscal year ended December 31, 2014,
7.Allocation of income for the fiscal year ended December 31,2014,
8.Review of the related party transaction referred to in articles L. 225-38 and following of the French Commercial Code (Code de Commerce),
9.Reappointment of Mr. André Choulika as a Director,
10.Reappointment of Mr. David Sourdive as a Director,
11.Reappointment of Mr. Alain Godard as a Director,
12.Appointment of a new Director (Mr. Jean-Marie Messier),
13.Approval of the regulations pertaining to the stock option or stock purchase plan adopted by the Board of Directors on March 24, 2015,
Agenda for the Extraordinary General Meeting
1.Amendment of Article 18 of the Company’s Articles of Association to comply with Decree No. 2014-1466 dated December 8, 2014.
|